INVO Bioscience, Inc., a commercial-stage fertility company, has entered an exclusive distribution agreement with Onesky Holdings Limited (Onesky) for Mainland China (excludes Hong Kong, Macau and Taiwan). Onesky will be responsible to register the product in the country, and upon government approval, will be obligated to purchase minimum quantities of INVOcell totalling approximately $14 million over the initial five-year term after approval. Customary additional terms and conditions apply, including term renewals.
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions! Learn More!